Today we'll discuss an important trial on febuxostat (ulloric), which raises important concerns about its safety from a cardiovascular perspective. Be sure to tune in to the #RheumJC discussion that will be happening this Thursday!
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"The Evidence Based Rheumatology Podcast","authorlink":""},"src":"https:\/\/mcdn.podbean.com\/mf\/web\/qezrs4\/E14-_Cardiovascular_Safety_of_Febuxostat_-_2.mp3","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202211\/633496-0633-b9b6-7f2bb9_800.jpg"},"title":"E14: Cardiovascular Safety of Febuxostat","link":"javascript:;","id":"item-262731"}]
